Pacira BioSciences Inc.

NASDAQ: PCRX · Real-Time Price · USD
25.08
0.09 (0.36%)
At close: Aug 15, 2025, 2:49 PM

Pacira BioSciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.85M 4.81M 16.04M -143.47M 18.89M 8.98M 24.87M 10.86M 25.76M -19.54M -10.1M -693K 19.88M 6.83M -5.13M 17.66M 19.08M 10.37M
Depreciation & Amortization
27.32M 21.17M 21.24M 20.25M 18.86M 18.43M 18.48M 18.43M 19.05M 19.6M 30.41M 20.2M 20.86M 20.03M 13.07M 5.73M 4.9M 4.85M
Stock-Based Compensation
15.47M 14.55M 12.27M 13.23M 12.52M 13.15M 12.42M 12.53M 10.96M 11.99M 12.68M 12.68M 11.54M 11.19M 10.89M 10.79M 10.46M 10.11M
Other Working Capital
1.33M -1.33M 2.06M -62K -4.33M 3.6M 1.86M 1.76M -8.24M -10.91M 393K -1.71M -8.44M -13.35M 24.61M 1.93M -574K -19.47M
Other Non-Cash Items
-25.46M -7.7M 4.41M 166.51M 45.11M 42.46M 854K 5.91M -17.5M 30.13M 22.1M 10.63M -19.43M 841K 6.7M 5.39M 3.33M 5.33M
Deferred Income Tax
752K 1.4M 3.51M 1.11M 12.54M 3.46M 6.6M 4.91M 11.44M -7.34M -10.84M 702K 2.16M 29K -2.08M 5.34M 5.87M 1.75M
Change in Working Capital
-1.22M 1.22M -24.33M -3.73M -4.38M 8.11M -15.65M -8.2M -6.21M -15.72M -2.21M -867K -5.22M -8.14M -236K 15.38M -13.5M -20.32M
Operating Cash Flow
12.01M 35.46M 33.13M 53.92M 53.24M 49.1M 47.58M 44.44M 43.5M 19.13M 42.04M 42.65M 29.81M 30.78M 23.21M 60.29M 30.13M 12.08M
Capital Expenditures
-2.7M -8.55M -2.12M -4.09M -1.59M -2.84M -1.8M -3.39M -3.4M -6.57M -5.49M -5.18M -11.73M -7.67M -9.17M -13.08M -10.55M -13.07M
Cash Acquisitions
n/a -16.7M n/a n/a n/a n/a -10.17M 948K -10.73M -72.75M 12.75M 42.34M n/a -12.75M -420.04M -2.97M -9.06M 1.22M
Purchase of Investments
-6.31M -69.63M -45.2M -101.24M -49.73M -56.05M -25.93M -42.17M -22.77M -53.5M -68.26M -132.03M -44.79M -155.6M -98M -195.36M -130.26M -187.87M
Sales Maturities Of Investments
71.17M 69.25M 46.95M 53.16M 36.1M 43.36M 36.1M 41.23M 33.5M 126.25M 84.94M 89.7M 62.94M n/a 598.12M 176.33M 158.06M 145.28M
Other Investing Acitivies
n/a n/a n/a n/a -13.63M -12.69M 10.17M -948K 10.73M 72.75M -12.75M -42.34M 12.75M -32M -4M -22M -5.16M -1.22M
Investing Cash Flow
62.16M -25.63M -368K -52.16M -15.21M -15.53M 8.37M -4.34M 7.33M 66.18M 11.19M -47.52M 19.16M -208.02M 66.92M -35.08M 3.03M -55.66M
Debt Repayment
n/a -2.81M -2.81M -2.81M 85.05M -2.81M -2.81M -27.81M -2.81M -147.32M -59.38M -9.38M -166.34M -192.61M 359.2M n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 25M -25M -4K -106K n/a n/a n/a 2.95M n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -2.67M n/a n/a n/a
Other Financial Acitivies
-53.76M -181K 857K -32K -60.07M -4K 1.03M 25K 3.25M -6.91M 864K 1.6M 12.68M 11.02M -3.83M 3.05M 5.91M 10.32M
Financial Cash Flow
-57.51M -2.99M -1.96M -2.85M 24.98M -2.82M -1.78M -27.79M 440K -153.91M -58.51M -7.78M -153.66M -181.59M 361.41M 3.05M 5.91M 10.32M
Net Cash Flow
16.87M 6.84M 30.81M -1.09M 63M 30.75M 54.18M 12.31M 51.27M -68.59M -5.29M -12.64M -104.69M -358.83M 451.54M 28.26M 39.08M -33.26M
Free Cash Flow
9.31M 26.91M 31.01M 49.83M 51.65M 46.27M 45.79M 41.04M 40.09M 12.56M 36.55M 37.47M 18.07M 23.11M 14.05M 47.21M 19.58M -992K